🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a randomized, double-blind, placebo-controlled, parallel group stud...
Status
Completed
Location
Multiple Locations
Start Date
2014-10
Trial ID
NCT02277743
Treatments Being Tested
Primary Objective: This study aimed to demonstrate the efficacy of dupilum...
Status
Completed
Location
California Allergy and Asthma Medical Group, Inc. Site Number : 8400019
Start Date
2019-12-11
Trial ID
NCT04180488
Treatments Being Tested
Primary Objective: To evaluate the efficacy of dupilumab administered ever...
Status
Completed
Location
SEC Clinical Research, LLC-Site Number:8400030
Start Date
2019-04-15
Trial ID
NCT03930732
Primary Objective: To evaluate the effect of dupilumab, compared to placeb...
Status
Completed
Location
Investigational Site Number 840402
Start Date
2016-01-27
Trial ID
NCT02573233
This is a multi-center, double-blind, placebo-controlled, randomized trial ...
Status
Active Not Recruiting
Location
Children's Hospital Colorado: Allergy Program
Start Date
2022-05-04
Trial ID
NCT05347771
The overarching objective of this study is to determine the clinical effect...
Status
Completed
Location
Johns Hopkins University School of Medicine
Start Date
2020-10-15
Trial ID
NCT04362501
This is a multi-center, double-masked, randomized, placebo-controlled, para...
Status
Unknown
Location
Premiere Practice Management, LLC
Start Date
2020-02-10
Trial ID
NCT04296864
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of bermeki...
Status
Terminated
Location
California Allergy & Asthma Medical Group Inc.
Start Date
2021-05-03
Trial ID
NCT04791319
Treatments Being Tested
The goal of this study is to research Dupilumab, an FDA approved medication...
Status
Recruiting
Location
University of California San Diego (UCSD) Health Medical center
Start Date
2024-11-10
Trial ID
NCT06665971
Treatments Being Tested
The investigators believe that administering Dupilumab during the pre- and ...
Status
Completed
Location
Centre Hospitalier de l'Université de Montréal (CHUM)
Start Date
2021-05-25
Trial ID
NCT04596189
Treatments Being Tested